Replies to post #89970 on Ayala Pharmaceuticals Inc (ADXS)

[Jesspro]

Given that you said around June of last year that NEO and HOT are targeting the same indication, did you ever think that because NEO is more expensive to make than HOt, that this the reason why they bailed out?

[NY1972]

AMGN pullout and Ken's refocus on Aim2Cerv ought to tell you something.